The US FDA has approved a human papillomavirus (HPV) self-sampling solution developed by Roche that allows patients to collect a sample themselves in a healthcare setting. The company says that the ...

Roche has launched what it says is a first-of-its-kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliver care to ...

Scholar Rock gets first FDA nod for rare muscle-wasting disease The U.S. Food and Drug Administration approved Scholar Rock's therapy on Friday to treat a rare genetic condition that causes muscle ...

Sector and region weightings are calculated using only long position holdings of the portfolio. The performance data shown in tables and graphs on this page is calculated in GBX of the ...

The Sub-Fund seeks to provide principal preservation and long term capital appreciation by offering an exposure to Global Equities. There is however no guarantee that the Sub-Fund will achieve its ...

With UV and Visible Spectrum capabilities, over 250 pre-programmed methods including the most common testing methods used, guided procedures, and integrated quality assurance software, the DR 6000 ...

Legg Mason Part. Investment TRT-ClearBridge Dividend Strategy Fd. 2.98M Jun 30, 2026 0.05% 157,139,499 Legg Mason Partners Investment Trust-ClearBridge Large Cap Growth Fund 1.85M May 31, 2026 0.03% ...

To bring cutting-edge diagnostic platforms to clinical use, Roche introduced the AXELIOS sequencing-by-expansion (SBX) ...

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as ...